期刊文献+

孕妇孕中期唐氏综合征筛查血清AFP、Free-β-HCG、uE3中位数倍数的临床意义 被引量:1

Clinical significance of MOM of maternal serum AFP、 Free-β-HCG、uE3 in second-trimester Down′s sydrome screening
原文传递
导出
摘要 目的探讨孕中期唐氏征筛查检查中AFP、Free-β-HCG、uE3中位数倍数(MOM)结果与胎儿染色体异常及其他先天畸形的关系。方法回顾性分析2009.1-2010.1在我院接受孕中期唐氏征筛查并成功随访的4250例单胎孕妇血清学筛查MOM(multiples of median)值结果与胎儿染色体异常及其他畸形发生情况。结果在4250例孕妇中,共筛查出有MOM值异常404例,其中染色体异常7例,神经管缺陷及其他畸形14例。血清学MOM值正常孕妇中发现21-三体1例,其他胎儿畸形13例,两组比较,胎儿染色体异常及其他畸形发生率有显著差距。结论孕中期血清学筛查指标MOM值异常对胎儿染色体异常,神经管缺陷及其他先天异常的发现均有一定的预测价值。 Objective: To investigate the relationship between MOM of maternal serum AFP、Free-β-HCG、uE3 in second-trimester and fetal chromosomal abnormalities and the other congenital deformity.Methods: A retrospective analysis about serologic screening of pregnant MOM(multiples of median) value in the second trimester and fetal chromosomal abnormalities and other malformationsin was performed,including 4250 single fetal cases with Down′s screening and follow-up in 2009.1-2010.1 in our hospital.Results: In these cases,there were 404 cases with the abnormal value of MOM,7 cases of chromosome abnormalities,and neural tube defects and other malformation in 14 cases.There was 1 cases of Trisomy 21 symdrome and 13 cases of the other fetal malformation in pregnant women with normal Serum MOM values.The two groups had significant difference in the rate of chromosomal abnormalities and other malformation.Conclusion: the abnormal value of MOM in the second trimester is related to fetal chromosomal abnormalities、neural tube defects and other congenital abnormalities.
出处 《中国优生与遗传杂志》 2012年第6期30-32,共3页 Chinese Journal of Birth Health & Heredity
关键词 唐氏征筛查 甲胎蛋白 游离β链人绒毛膜促性腺激素 游离雌三醇 中位数倍数 Screening of Down′s Syndrome AFP Free-β-HCG uE3 unconjugated estriol MOM(multiples of median)
  • 相关文献

参考文献8

  • 1Cuckle H.Biochemical screening for Down syndrome[].European Journal of Obstetrics Gynecology and Reproductive Biology.2000
  • 2Gillespie JR,Uversky VN.Structure and function of alpha-fetoprotein: a biophysical overview[].Biochimica et Biophysica Acta.2000
  • 3Cuckle HS,Wald NJ,Thompson SG.Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level[].British Journal of Obstetrics and Gynaecology.1987
  • 4Kiran TS,Bethel J,Bhal PS.Correlation of abnormal second trimester maternal serum lpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome[].Journal of Obstetrics and Gynaecology.2005
  • 5AO Odibo,HM Sehdev,DM Stamilio,GA Macones.Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction[].The American Journal of Perinatology.2006
  • 6Wald NJ,Morris JK,Ibison Jet al.Screening in early pregnancy forpre-eclampsia using Down syndrome quadruple test markers〔J〕[].Prenatal Diagnosis.2006
  • 7Hoffman JD,Bianchi DW,Sullivan LM,et al.Down syndrome serumscreening also identifies an increased risk for multicystic dysplastickidney,two-vessel cord,and hydrocele[].Prenatal Diagnosis.2008
  • 8Mizejewski GJ.Biological roles of alpha-fetoprotein during pregnan-cy and perinatal development[].Experimental Biology and Medicine.2004

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部